Skip to Content
Morningstar

Putnam Global Health Care R PHSRX

Morningstar Medalist Rating
Medalist Rating as of | See Franklin Templeton Investment Hub
  • NAV / 1-Day Return 53.14  /  −0.43 %
  • Total Assets 1.7 Bil
  • Adj. Expense Ratio
    1.320%
  • Expense Ratio 1.320%
  • Distribution Fee Level Below Average
  • Share Class Type Retirement, Medium
  • Category Health
  • Investment Style Large Growth
  • Min. Initial Investment —
  • Status Open
  • TTM Yield —
  • Turnover 41%

USD | NAV as of Apr 15, 2024 | 1-Day Return as of Apr 15, 2024, 11:32 PM GMT+0

Morningstar’s Analysis PHSRX

Will PHSRX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

  • Process Pillar

    The Process Pillar is our assessment of how sensible, clearly defined, and repeatable PHSRX’s performance objective and investment process is for both security selection and portfolio construction.

  • People Pillar

    The People Pillar is our evaluation of the PHSRX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.

  • Parent Pillar

    The Parent Pillar is our rating of PHSRX’s parent organization’s priorities and whether they’re in line with investors’ interests.

A strong management team and sound investment process underpin Putnam Global Health Care R's Morningstar Medalist Rating of Bronze.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-highest quintile among peers.

by Morningstar Manager Research
Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings PHSRX

More PHSRX Holdings
  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 58.7
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

UnitedHealth Group Inc

8.30 147.2 Mil
Healthcare

Eli Lilly and Co

7.68 136.3 Mil
Healthcare

AbbVie Inc

7.59 134.6 Mil
Healthcare

Intuitive Surgical Inc

6.08 107.9 Mil
Healthcare

AstraZeneca PLC

5.62 99.6 Mil
Healthcare

Novo Nordisk A/S Class B

5.09 90.4 Mil
Healthcare

Boston Scientific Corp

5.05 89.6 Mil
Healthcare

Thermo Fisher Scientific Inc

4.55 80.7 Mil
Healthcare

Innoviva Inc

4.41 78.3 Mil
Healthcare

Ascendis Pharma A/S ADR

4.34 77.0 Mil
Healthcare